EP3383916
AND-CD73-MÓTEFNI OG NOTAGILDI ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.1.2018EP published:
23.2.2022EP application number:
18733153.3
EP translation filed:
16.4.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
22.1.2038Expiry date:
22.1.2027Next due date:
31.1.2027
Title in English:
ANTI-CD73 ANTIBODIES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
23.1.2018EP application
23.2.2022EP Publication
16.4.2022Translation submitted
15.6.2022Registration published
22.1.2027Expires
Owner
Name:
I-Mab Biopharma Co., Ltd.Address:
Rm802, 8F, 1Bld., West Tower, 88 Shangke Rd., Pudong, Shanghai, P.R. China 201210, CN
Inventor
Name:
WANG, ZhengyiAddress:
Shanghai 201210, CN
Name:
FANG, LeiAddress:
Shanghai 201210, CN
Name:
GUO, BingshiAddress:
Shanghai 201210, CN
Name:
ZANG, JingwuAddress:
Shanghai 201210, CN
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
PCT/CN2017/072445Date:
24.1.2017Country:
WO
Classification
Categories:
C07K 16/28, C07K 16/40, A61K 39/395, A61P 35/00, G01N 33/53, G01N 33/574, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.12.2022
Expires: 22.1.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 18.12.2023
Expires: 22.1.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.12.2024
Expires: 22.1.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.12.2025
Expires: 22.1.2027
Payer: UAB METIDA